日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial

MAT2A抑制剂AG-270/S095033治疗晚期恶性肿瘤患者:一项I期试验

Gounder, Mrinal; Johnson, Melissa; Heist, Rebecca S; Shapiro, Geoffrey I; Postel-Vinay, Sophie; Wilson, Frederick H; Garralda, Elena; Wulf, Gerburg; Almon, Caroline; Nabhan, Salah; Aguado-Fraile, Elia; He, Peng; Romagnoli, Mathilde; Hossain, Mohammad; Narayanaswamy, Rohini; Sadou-Dubourgnoux, Amel; Cooper, Michael; Askoxylakis, Vasileios; Burris, Howard A; Tabernero, Josep

A phase III, open-label clinical trial evaluating pegunigalsidase alfa administered every 4 weeks in adults with Fabry disease previously treated with other enzyme replacement therapies

一项 III 期开放标签临床试验,评估每 4 周一次的培尼加糖苷酶 alfa 对既往接受过其他酶替代疗法治疗的法布里病成人患者的疗效。

Holida, Myrl; Linhart, Aleš; Pisani, Antonio; Longo, Nicola; Eyskens, François; Goker-Alpan, Ozlem; Wallace, Eric; Deegan, Patrick; Tøndel, Camilla; Feldt-Rasmussen, Ulla; Hughes, Derralynn; Sakov, Anat; Rocco, Rossana; Almon, Einat Brill; Alon, Sari; Chertkoff, Raul; Warnock, David G; Waldek, Stephen; Wilcox, William R; Bernat, John A

Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study

在患有法布里病且肾功能恶化的患者中,培尼加糖酶α与阿加糖酶β的头对头试验:来自为期2年的随机III期BALANCE研究的结果

Wallace, Eric L; Goker-Alpan, Ozlem; Wilcox, William R; Holida, Myrl; Bernat, John; Longo, Nicola; Linhart, Aleš; Hughes, Derralynn A; Hopkin, Robert J; Tøndel, Camilla; Langeveld, Mirjam; Giraldo, Pilar; Pisani, Antonio; Germain, Dominique Paul; Mehta, Ankit; Deegan, Patrick B; Molnar, Maria Judit; Ortiz, Damara; Jovanovic, Ana; Muriello, Michael; Barshop, Bruce A; Kimonis, Virginia; Vujkovac, Bojan; Nowak, Albina; Geberhiwot, Tarekegn; Kantola, Ilkka; Knoll, Jasmine; Waldek, Stephen; Nedd, Khan; Karaa, Amel; Brill-Almon, Einat; Alon, Sari; Chertkoff, Raul; Rocco, Rossana; Sakov, Anat; Warnock, David G

Tryptophan as a biomarker of pregnancy-related immune expression and modulation: an integrative review

色氨酸作为妊娠相关免疫表达和调节的生物标志物:一项综合性综述

Prescott, Stephanie; Billeci, Natasa; Gotcher, Melissa; Patel, Sapna; Almon, Addison; Morgan, Hailey; Abukhalaf, Danielle; Groer, Maureen

Super-pulsed Diode Laser in the Therapy of Inferior Alveolar Nerve Paresthesia After Mandibular Third Molar Extraction: A Case Report

超脉冲二极管激光治疗下颌第三磨牙拔除术后下牙槽神经感觉异常:病例报告

Brito, Aubert V Sr; Angulo, Arlyn; Almon, Ricardo

Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study

一项 BRIDGE 3 期开放标签研究的结果显示,在既往接受过阿加糖酶 alfa 治疗的法布里病患者中,培尼加糖酶 alfa 的安全性和有效性

Linhart, Aleš; Dostálová, Gabriela; Nicholls, Kathy; West, Michael L; Tøndel, Camilla; Jovanovic, Ana; Giraldo, Pilar; Vujkovac, Bojan; Geberhiwot, Tarekegn; Brill-Almon, Einat; Alon, Sari; Chertkoff, Raul; Rocco, Rossana; Hughes, Derralynn

A comparison of point-tracking algorithms in ultrasound videos from the upper limb

上肢超声视频中点跟踪算法的比较

Magana-Salgado, Uriel; Namburi, Praneeth; Feigin-Almon, Micha; Pallares-Lopez, Roger; Anthony, Brian

Impact of multi-agent systemic therapy on all-cause and disease-specific survival for people living with HIV who are diagnosed with non-Hodgkin lymphoma: population-based analyses from the state of Georgia

多药联合系统治疗对合并非霍奇金淋巴瘤的 HIV 感染者全因生存率和疾病特异性生存率的影响:来自佐治亚州的基于人群的分析

Lipscomb, Joseph; Switchenko, Jeffrey M; Flowers, Christopher R; Gillespie, Theresa W; Wortley, Pascale M; Bayakly, A Rana; Almon, Lyn; Ward, Kevin C

Pharmacokinetic/Pharmacodynamic Evaluation of Ivosidenib or Enasidenib Combined With Intensive Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed IDH1/2-Mutant Acute Myeloid Leukemia

对新诊断的IDH1/2突变型急性髓系白血病患者,采用伊沃西尼布或恩西地尼布联合强化诱导和巩固化疗的药代动力学/药效学评价

Fan, Bin; Chen, Yue; Yin, Feng; Hua, Lei; Almon, Caroline; Nabhan, Salah; Cooper, Michael; Yang, Hua; Hossain, Mohammad

Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study

伊沃西尼布或伊那西尼布联合强化化疗治疗新诊断急性髓系白血病患者:一项 1 期研究

Stein, Eytan M; DiNardo, Courtney D; Fathi, Amir T; Mims, Alice S; Pratz, Keith W; Savona, Michael R; Stein, Anthony S; Stone, Richard M; Winer, Eric S; Seet, Christopher S; Döhner, Hartmut; Pollyea, Daniel A; McCloskey, James K; Odenike, Olatoyosi; Löwenberg, Bob; Ossenkoppele, Gert J; Patel, Prapti A; Roshal, Mikhail; Frattini, Mark G; Lersch, Frederik; Franovic, Aleksandra; Nabhan, Salah; Fan, Bin; Choe, Sung; Wang, Hongfang; Wu, Bin; Hua, Lei; Almon, Caroline; Cooper, Michael; Kantarjian, Hagop M; Tallman, Martin S